Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

OLED October 14, 2025

Universal Display Corporation Q2 2025 Earnings Call - Record Q2, raised guidance and phosphorescent blue commercialization milestone

Universal Display posted a clean, profitable quarter: $172 million in revenue, roughly $67 million in net income and gross margins near 77%. Management nudged the low end of full year guidance higher ...

  • Q2 revenue of $172 million, record quarterly performance reported by management.
  • Net income of $67 million, reported EPS approximately $1.40 to $1.41 per diluted share.
  • Company raised the low end of full year 2025 revenue guidance to a range of $650 million to $700 million.
  • +13 more takeaways
ENVX October 14, 2025

Enovix Q2 2024 Earnings Call - A1 platform in customer qualification as Fab 2 scales and warrant dividend funds buildout

Enovix reported a beat in Q2 with $7.5 million revenue, a 98% year over year rise, and a 31% non-GAAP gross margin driven by defense product sales. The call pivoted around the A1 platform, now sampled...

  • Revenue of $7.5 million beat guidance of $4.5 to $6.5 million and rose 98% year over year.
  • Non-GAAP gross margin reached 31%, helped by higher-margin defense product shipments from the acquired Korean facility.
  • Enovix launched the A1 platform, a 100% active silicon anode design claiming about 900 watt hours per liter, 3C charge capability, and a projected 1,000 cycle life, now in commercial qualification.
  • +12 more takeaways
WSC October 14, 2025

"WillScot Mobile Mini Holdings Corp." Q2 2025 Earnings Call - Sequential leasing revenue inflection and $130M Q2 adjusted free cash flow, but small-project demand remains weak

WillScot reported a steady quarter: adjusted EBITDA of $249 million, sequential leasing revenue growth, and robust cash generation even as smaller, interest-rate sensitive projects stayed soft. Manage...

  • Adjusted EBITDA was $249 million in Q2, with an adjusted EBITDA margin of 42.3% in the quarter and a trailing twelve month margin noted at 43.8%.
  • Adjusted free cash flow was $130 million in Q2, a 22.1% margin, and the last 12 months generated $555 million of adjusted free cash flow (24% margin, $3.05 per share).
  • Leasing revenue inflected positively on a sequential basis, up 2% in Q2, the first sequential leasing revenue growth (ex Q4 seasonality) since Q3 2023. Management views this as the first step back toward year over year revenue growth.
  • +12 more takeaways
LUMN October 14, 2025

Lumen Technologies Q2 2025 Earnings Call - AT&T sale unlocks $5.75B to delever and fund AI-focused transformation

Lumen used Q2 to turn strategy into action. The company agreed to sell its consumer fiber-to-the-home business to AT&T for $5.75 billion, tightened its balance sheet with a $2 billion bond refi, and p...

  • Lumen agreed to sell its consumer fiber-to-the-home business to AT&T for $5.75 billion, a transaction management says provides strategic clarity and a path to materially delever.
  • Management plans to use proceeds to pay down about $4.8 billion of super priority debt at close, which should cut annual interest expense by roughly $300 million, reduce CapEx by about $1 billion, and lower leverage by roughly one turn.
  • The company completed a $2 billion bond offering that extended maturities into 2033 and cut coupon rates by more than 3.5 percentage points, saving roughly $50 million of annual interest expense; combined actions this year reduce annual interest by about $100 million so far.
  • +17 more takeaways
HTGC October 14, 2025

Hercules Capital Q2 2025 Earnings Call - Record fundings and >$1B originations, balance sheet kept conservative

Hercules Capital closed Q2 2025 by doubling down on scale while refusing to chase yield. The firm reported a second consecutive quarter of more than $1 billion in total gross debt and equity commitmen...

  • Record originations continued, with over $1 billion of total gross debt and equity commitments in Q2, marking the second consecutive quarter above $1 billion.
  • Q2 gross fundings hit a record $709.1 million, up 53.7% year over year.
  • Net debt portfolio grew by $192.1 million in Q2, and grew over $461.9 million in the first half of 2025.
  • +14 more takeaways
FRSH October 14, 2025

Freshworks Q2 2025 Earnings Call - Strong Revenue, Margin Expansion, and Early AI Monetization

Freshworks reported a robust Q2, balancing double digit growth with marked margin expansion. Revenue rose 18% year over year to $204.7M, non GAAP operating margin expanded to 22%, and adjusted free ca...

  • Q2 revenue $204.7M, up 18% year over year, 17% constant currency.
  • Non GAAP operating margin widened to 22%, non GAAP gross margin was 86%.
  • Adjusted free cash flow $54.3M in Q2, representing a 27% adjusted FCF margin, up 65% year over year.
  • +12 more takeaways
NMIH October 14, 2025

National MI Second Quarter 2025 Earnings Call - Record revenue and portfolio growth with a $1.3B capital cushion

National MI delivered a clean, robust quarter: record total revenue of $173.8M, $12.5B of new insurance written and a record $214.7B of primary insurance in force. Adjusted net income was $96.5M ($1.2...

  • NIW: $12.5 billion of new insurance written in Q2; primary insurance in force reached a record $214.7 billion, up 2% q/q and 5% y/y.
  • Financials: Record total revenue of $173.8 million; adjusted net income of $96.5 million, or $1.22 diluted EPS; adjusted ROE 16.3%.
  • Premiums & yields: Net premiums earned were $149.1 million; net yield 28 bps; core yield (ex reinsurance and cancellations) 34.2 bps, up slightly q/q.
  • +11 more takeaways
BIO October 14, 2025

Bio-Rad Laboratories Q2 2025 Earnings Call - Process chromatography surge, Stilla lift ddPCR, tariffs ease margin pressure

Bio-Rad delivered a beat in Q2 with $652 million in sales, modest organic growth, and an upgraded outlook driven by a stronger-than-expected process chromatography business, the closing of the Stilla ...

  • Q2 revenue $652 million, up 2.1% reported versus Q2 2024, and roughly 1% on a currency-neutral basis.
  • Life Science sales were $263 million, up 4.9% reported and 3.8% currency neutral, led by process chromatography and food safety products.
  • Process chromatography showed strong double-digit growth for the quarter, with approximately 20% of process chromatography orders pulled into Q2 by customers.
  • +12 more takeaways
NVST October 14, 2025

Envista Holdings Corporation Second Quarter 2025 Earnings Call - Guidance Raised as Ops Progress Offsets FX and Tariff Headwinds

Envista turned in a constructive quarter, posting $682 million in sales and 5.6% core growth, and used that momentum to lift full year targets. Adjusted EBITDA margin widened to 12.4% and adjusted EPS...

  • Q2 sales $682 million, core revenue growth 5.6% year over year, with FX adding roughly 200 basis points to reported growth.
  • Adjusted EBITDA margin 12.4%, up 240 basis points versus Q2 2024; adjusted EPS $0.26, up $0.15 year over year.
  • 2025 guidance raised: core revenue growth to 3 to 4% (from 1 to 3%), adjusted EPS to $1.05 to $1.15 (up $0.10), adjusted EBITDA margin unchanged at about 14%.
  • +13 more takeaways
WK October 14, 2025

Workiva Q2 2025 Earnings Call - Platform-led subscription growth lifts revenue and margins despite sustainability moderation

Workiva posted a strong Q2, beating the high end of revenue guidance with $215 million in total revenue and $198 million in subscription revenue, driving 21% and 23% year over year growth respectively...

  • Q2 results beat: Total revenue $215 million, up 21% year over year; subscription revenue $198 million, up 23% year over year, beating the high end of guidance by $5 million.
  • Raised full-year revenue guide to $870 million to $873 million and increased non-GAAP operating margin guidance to 7% to 7.5% for 2025, reflecting anticipated margin expansion in H2.
  • Q3 guidance: total revenue $218 million to $220 million; company expects services revenue to be down year over year as low margin services shift to partners.
  • +12 more takeaways